146 related articles for article (PubMed ID: 11786107)
1. Patients with Fabry disease on dialysis in the United States.
Thadhani R; Wolf M; West ML; Tonelli M; Ruthazer R; Pastores GM; Obrador GT
Kidney Int; 2002 Jan; 61(1):249-55. PubMed ID: 11786107
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease.
Talbot AS; Lewis NT; Nicholls KM
Heart; 2015 Feb; 101(4):287-93. PubMed ID: 25381325
[TBL] [Abstract][Full Text] [Related]
3. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
4. Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapy.
Mignani R; Feriozzi S; Schaefer RM; Breunig F; Oliveira JP; Ruggenenti P; Sunder-Plassmann G
Clin J Am Soc Nephrol; 2010 Feb; 5(2):379-85. PubMed ID: 20056752
[TBL] [Abstract][Full Text] [Related]
5. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
[TBL] [Abstract][Full Text] [Related]
6. Kidney transplant outcomes in patients with Fabry disease.
Shah T; Gill J; Malhotra N; Takemoto SK; Bunnapradist S
Transplantation; 2009 Jan; 87(2):280-5. PubMed ID: 19155985
[TBL] [Abstract][Full Text] [Related]
7. Survival among patients with kidney failure in Jalisco, Mexico.
Garcia-Garcia G; Briseño-Rentería G; Luquín-Arellan VH; Gao Z; Gill J; Tonelli M
J Am Soc Nephrol; 2007 Jun; 18(6):1922-7. PubMed ID: 17494884
[TBL] [Abstract][Full Text] [Related]
8. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
Wong CF; McCarthy M; Howse ML; Williams PS
Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
[TBL] [Abstract][Full Text] [Related]
10. Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States.
Stack AG; Murthy BV; Molony DA
Kidney Int; 2004 Jun; 65(6):2398-408. PubMed ID: 15149353
[TBL] [Abstract][Full Text] [Related]
11. Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study.
Abbott KC; Glanton CW; Trespalacios FC; Oliver DK; Ortiz MI; Agodoa LY; Cruess DF; Kimmel PL
Kidney Int; 2004 Feb; 65(2):597-605. PubMed ID: 14717930
[TBL] [Abstract][Full Text] [Related]
12. Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan.
Hwang SJ; Yang WC; Lin MY; Mau LW; Chen HC;
Nephrol Dial Transplant; 2010 Aug; 25(8):2616-24. PubMed ID: 20519231
[TBL] [Abstract][Full Text] [Related]
13. The current state of chronic dialysis treatment in Japan (as of December 31, 2000).
Ther Apher Dial; 2003 Feb; 7(1):3-35. PubMed ID: 12921111
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic microangiopathy in United States long-term dialysis patients.
Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
[TBL] [Abstract][Full Text] [Related]
15. Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival.
Abbott KC; Agodoa LY
Clin Nephrol; 2001 Sep; 56(3):207-10. PubMed ID: 11597035
[TBL] [Abstract][Full Text] [Related]
16. Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population.
Obrador GT; Arora P; Kausz AT; Ruthazer R; Pereira BJ; Levey AS
Kidney Int; 1999 Dec; 56(6):2227-35. PubMed ID: 10594799
[TBL] [Abstract][Full Text] [Related]
17. Significance of screening for Fabry disease among male dialysis patients.
Ichinose M; Nakayama M; Ohashi T; Utsunomiya Y; Kobayashi M; Eto Y
Clin Exp Nephrol; 2005 Sep; 9(3):228-32. PubMed ID: 16189631
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.
Wolfe RA; Ashby VB; Milford EL; Ojo AO; Ettenger RE; Agodoa LY; Held PJ; Port FK
N Engl J Med; 1999 Dec; 341(23):1725-30. PubMed ID: 10580071
[TBL] [Abstract][Full Text] [Related]
19. End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry.
Ortiz A; Cianciaruso B; Cizmarik M; Germain DP; Mignani R; Oliveira JP; Villalobos J; Vujkovac B; Waldek S; Wanner C; Warnock DG
Nephrol Dial Transplant; 2010 Mar; 25(3):769-75. PubMed ID: 19846394
[TBL] [Abstract][Full Text] [Related]
20. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
